Tag Archives: Genentech

Roche Unsweetens Genentech Pot and Takes it to the Shareholders

By George Koroneos | Published: January 30, 2009
Image by Getty Images via Daylife Roche wants Genentech and it’s sick of waiting for a deal. Six months after a special committee for the biotech firm’s board of directors rejected Roche’s offer of $43.7 billion or $89 a share, Roche has switched gears and dropped the offer to $86.50 per share and is taking negotiations to [...]
Posted in Deals | Also tagged , , , , | 1 Comment

JP Morgan Healthcare Conference:
It’s All About "Money…Rather the Economy!"

By Audrey Erbes | Published: January 15, 2009
JP Morgan’s Healthcare Conference has always been about financing, but money has never been the main focus like it is at this year’s annual gathering in San Francisco. The hallmark of this investment meeting has been innovation, with companies passionately pitching their new product or technology and management team’s capability to execute on a [...]
Posted in Events | Also tagged , , , , , , , , , , , | 1 Comment

What a Week! Roche and Genentech … and Mirus!?!

By Walter Armstrong | Published: July 25, 2008
The big news this week—and, for that matter, this year—is Roche’s offer to buy the 44 percent of Genentech that it doesn’t already own. The blogosphere is burning with all the predictable predictions, dire and otherwise, attendant on a big pharma takeover of a biotech. The phrase “killing the goose that’s been laying the golden [...]
Posted in Biotech, Deals, Gene therapy, R&D, Strategy, Technology | Also tagged , , , , | 1 Comment